Delivery Order SPE2DB20D3103-SPE2DB21FQ3V1

Award Date 9/21/21
Potential Completion Date 9/22/21
Potential Value $5.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DX15D2205|SPE2DX24F76JU was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product, with a ceiling value of $3,817.18 and an ultimate completion date of January 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
This federal contract award is for the delivery of Tetracaine 0.5% Eye, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,320.01, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a Ceiling Value of $2,799.06 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,547.48 firm fixed-price delivery order is for the supply of 4564352542 ! TETRACAINE 1% (20 MG/2 ML) VL 2ML, a pharmaceutical product. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of tetracaine 0.5% steri-unit solution (4 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,941.72 firm fixed price delivery order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,701.85, is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product. The contract has a period of performance through April 9, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,130.46 firm fixed-price delivery order is for the supply of TETRACAIN HCL 0.5% 12S, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TETRACAINE 0.5% EYE 1S medication with a ceiling value of $4,133.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. The contract is not designated with a set-aside and was awarded on...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,484.99, is a delivery order for the supply of Tetracaine 0.5% Steri-Unit Solution, a medication used for pain relief. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FBEE8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,477,022 units of Tetracaine 0.5% Steri-Unit solution in 4 mL containers. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,780.70 and an ultimate completion date of August 19, 2024. This award is not associated with a set-aside program....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FQ3V1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,542.08 firm fixed-price delivery order covers the supply of Tetracaine 0.5% Steri-Unit Solution, a medical product used for topical anesthesia. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. This contract award demonstrates Amerisourcebergen's critical role as a key vendor for the federal government, particularly the Department of Defense, in supplying essential medical commodities to military treatment facilities and veteran healthcare programs.

Generated 2/27/25, 12:19 PM